Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination

Area of Science:

• Oncology
• Cell Biology
• Immunology

Background:

• Platelet endothelial cell adhesion molecule-1 (PECAM-1) is expressed on vascular endothelium and influences tumor progression.
• PECAM-1's role in modulating the tumor microenvironment (TME) and promoting tumor cell proliferation is recognized.
• Its activity is linked to tumor microenvironment modulation and tumor cell proliferation, not angiogenesis.

Purpose of the Study:

• To investigate the role of functional PECAM-1 in promoting a proliferative tumor cell phenotype.
• To elucidate the mechanisms by which PECAM-1 influences tumor cell proliferation in vitro and in vivo.
• To identify specific factors regulated by PECAM-1 that contribute to tumor cell growth.

Main Methods:

• Co-culture assays using melanoma (B16-F10) and breast cancer (4T1) cell lines with mouse endothelial cells (ECs) or a surrogate EC line (REN-MP).
• Analysis of conditioned media from co-cultures to identify soluble endothelial-derived factors.
• Assessment of TIMP metallopeptidase inhibitor-1 (TIMP-1) as a PECAM-1-regulated factor.
• In vivo studies using PECAM-1-null mice to evaluate TIMP-1 expression in metastatic tumors.

Main Results:

• Endothelial PECAM-1 presence promoted a proliferative tumor cell phenotype in co-culture systems.
• Pro-proliferative effects were mediated by soluble factors dependent on PECAM-1 homophilic interactions, independent of PECAM-1 signaling.
• TIMP-1 was identified as a key PECAM-1-regulated factor; targeting TIMP-1 inhibited tumor cell proliferation.
• TIMP-1 expression was reduced in metastatic tumors from PECAM-1-null mice, confirming in vivo relevance.

Conclusions:

• Endothelial PECAM-1, via homophilic binding, induces TIMP-1 release into the TME.
• This PECAM-1-mediated TIMP-1 release contributes to increased tumor cell proliferation.
• Findings highlight a novel mechanism involving endothelial PECAM-1 and TIMP-1 in tumor progression.